| Trial ID: | L3347 |
| Source ID: | NCT02900417
|
| Associated Drug: |
Sitagliptin
|
| Title: |
Evaluation of the Effect of Sitagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Sitagliptin
|
| Outcome Measures: |
Primary: The changes of the composition of gut microbiota before and after the use of sitagliptin, 12 weeks | Secondary: Changes of HbA1c levels, 12 weeks|Changes of fasting plasma glucose levels, lipids levels and insulin sensitivity, 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: Second Affiliated Hospital of Soochow University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
9
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose:
|
| Start Date: |
2016-09
|
| Completion Date: |
2016-11
|
| Results First Posted: |
|
| Last Update Posted: |
2016-09-14
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT02900417
|
